Synthetic data onlyUnder further development and regulatory approval

CareFlow preview status

A preview, not a system for patient care.

CareFlow is an early preview of a practice-operations platform for Australian general practice, hosted on premises at the clinic. Everything it does today runs on invented data. It is not a diagnostic system, not a prescribing system, and not a source of clinical truth.

Boundaries

What this is not yet.

We publish these limits deliberately. A preview that overstates its own readiness is worse than no preview, because a practice could make a clinical decision on the strength of a marketing claim.

Not for real patient data

No real patient information should be entered, and none is authorised. Clinical, privacy, safety, terminology, accessibility, backup and incident-response approvals must each be recorded against registered evidence before real-data mode is permitted.

Not an e-prescribing system

Electronic prescribing exists only as a local conformance harness. It cannot transmit a prescription, cannot reach a pharmacy, and makes no claim of conformance with any Australian ePrescribing framework. There is no national pharmacy connectivity.

Not approved for clinical use

There is no regulatory approval, clinical safety case, independent penetration test or privacy impact assessment. Those are the next steps, not completed work.

Not a billing or claims system

Billing, claims, card and EFTPOS processing are deliberately disabled and cannot be enabled.

Scope

What the preview does demonstrate.

The value of the preview is that the safety boundaries are real and testable, not simulated. Each item below is enforced in code and covered by automated tests.

Practice operations

Multi-tenant scheduling with practitioner and room conflict protection, authorisation-required capacity overrides with immutable records, check-in, communication preferences and an append-only audit trail.

Clinical workflow boundaries

Clinician-authored record drafts that remain inactive until a prescriber with a verified second factor signs them, purpose-specific consent records, and prescription drafts that produce watermarked, non-dispensing previews only.

Document safety

Uploaded documents are quarantined and malware-scanned before anyone can read them, and a scanner failure keeps them locked rather than admitting them. Documents are encrypted with per-document keys wrapped by an independently managed key.

Separation of duties

Six roles with enforced boundaries: a nurse cannot sign a clinical record, reception cannot open the clinical workspace, and release approvals require named authorised roles rather than a single administrator.

Every role boundary is asserted, not assumed. Automated tests confirm that a nurse cannot sign a clinical record, that reception and audit roles cannot read clinical records, and that release approvals follow a role matrix instead of a single administrator permission.

Status

Development status.

Each status below changes only when there is evidence for the change, not when there is an intention to change it.

Data
Synthetic onlyReal patient data is not authorised. The platform refuses clinical data mode until every required approval is current.
Electronic prescribing
Not enabledRepresented by a non-transmitting local harness. No provider contract and no conformance claim.
Regulatory approval
In progressNot held.
Clinical safety case
Not startedRequires independent clinical review and a hazard analysis.
Privacy impact assessment
Not completedOutstanding.
Independent penetration test
Not commissionedOutstanding, including the identity-plane and worker roles.
Billing and payments
Disabled by designCannot be switched on in this release.

Why the status is public. Prospective users and reviewers need to know these limits before a demonstration, not after. Publishing them is the same principle as publishing a clinical safety case: the claim and its limits travel together.

Access

Requesting access to the preview.

The preview is demonstrated to interested practices and reviewers under a demonstration agreement, on synthetic data only. Access is granted per organisation.

Commercial discussion about future availability is welcome, but payment is not taken for clinical use before the approvals listed above exist. If that timeline does not suit your practice, we would rather say so now than take a deposit against a capability we cannot yet deliver safely.

See the boundaries for yourself

Evaluate the preview against your own requirements.

Bring your clinical, privacy, security and intended-use requirements and we will show exactly where the system stops, who is accountable for each decision, and what remains outstanding.